by John Conrad | Oct 28, 2024 | Member News, NewsBrief
AbbVie announced today it will acquire Boston-based Aliada Therapeutics in a $1.4 billion cash deal, expanding its presence in neuroscience and Alzheimer’s disease research. The acquisition gives AbbVie access to Aliada’s novel blood-brain barrier crossing...
by John Conrad | Aug 1, 2024 | NewsBrief
A team of researchers at the University of Illinois Urbana-Champaign (UIUC) has made a significant breakthrough in brain imaging technology that could revolutionize the diagnosis and treatment of Alzheimer’s disease. The study, published on July 31, 2024, in ACS...
by John Conrad | Aug 28, 2019 | iBIO News, Policy News
On August 26th Governor Pritzker signed SB 1726 which expanded Illinois Alzheimer’s Disease Advisory Committee and the Alzheimer’s Disease Research, Care and Support Fund. The bill also creates the full-time position of Dementia Coordinator within the Department of...
